UK's Futura Medical surges on license deal for Haleon's ED treatment

Futura Medical

17/07/2023 08:50

** Shares of Futura Medical Plc  FUM.L  jump as much as 17%
to 60.4p
    ** Stock among top pct gainers across all London stocks
    ** Co signs license agreement with Haleon  HLN.L  to
commercialize its gel-based erectile dysfunction (ED) treatment
MED3000 in U.S.
    ** Co to get initial upfront payment of $4 mln and royalty
on all Haleon sales of the treatment
    ** Shares marginally up 0.8% YTD, as of last close

 (Reporting by Anchal Rana in Bengaluru)
 ((Anchal.Rana@thomsonreuters.com; +91 9915609050;))